Eisai
4523.T
#2008
Rank
C$13.43 B
Marketcap
C$47.67
Share price
-0.53%
Change (1 day)
13.76%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2026 (TTM): C$0.52 Billion

According to Eisai's latest financial reports the company's current earnings are C$5.44 Billion. In 2025 the company made an earning of C$0.61 Billion a decrease over its 2024 earnings that were of C$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.52 B-15.08%
2025 C$0.61 B-20.48%
2024 C$0.77 B2.42%
2023 C$0.75 B-2404.04%
2022 -C$32.64 Million-103.6%
2021 C$0.90 B-39.81%
2020 C$1.50 B7.44%
2019 C$1.40 B17.22%
2018 C$1.19 B86.16%
2017 C$0.64 B-23.52%
2016 C$0.84 B26.97%
2015 C$0.66 B22.3%
2014 C$0.54 B-46.07%
2013 C$1.00 B-21.85%
2012 C$1.28 B-20.59%
2011 C$1.61 B-8.91%
2010 C$1.77 B19.21%
2009 C$1.48 B